Biotage AB (Sweden) Insiders
| BIOT Stock | SEK 155.00 3.90 2.58% |
Biotage AB employs about 510 people. The company is managed by 10 executives with a total tenure of roughly 1190 years, averaging almost 119.0 years of service per executive, having 51.0 employees per reported executive. Breaking down Biotage AB's management performance can provide insight into the firm performance.
| Tomas Blomquist Insider CEO Pres |
| Raffaella Bombarda Insider EVP Marketing |
Biotage |
Biotage AB Management Team Effectiveness
The company has return on total asset (ROA) of 0.109 % which means that it generated a profit of $0.109 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1785 %, meaning that it generated $0.1785 on every $100 dollars invested by stockholders. Biotage AB's management efficiency ratios could be used to measure how well Biotage AB manages its routine affairs as well as how well it operates its assets and liabilities.Biotage AB Workforce Comparison
Biotage AB is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 696. Biotage AB totals roughly 510 in number of employees claiming about 73% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Biotage AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biotage AB Price Series Summation is a cross summation of Biotage AB price series and its benchmark/peer.
Biotage AB Notable Stakeholders
A Biotage AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biotage AB often face trade-offs trying to please all of them. Biotage AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biotage AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Tomas Blomquist | CEO Pres | Profile | |
| Raffaella Bombarda | EVP Marketing | Profile | |
| Maja Nilsson | Chief Officer | Profile | |
| CS BSc | Ex Operations | Profile | |
| JonSverre Schanche | Chief Officer | Profile | |
| Olof Nord | Exec Devel | Profile | |
| Lars LLB | Chief Officer | Profile | |
| Petra Duprez | Chief Officer | Profile | |
| Jonas Stahlberg | Chief Auditor | Profile | |
| Scott Carr | Pres Americas | Profile |
About Biotage AB Management Performance
The success or failure of an entity such as Biotage AB often depends on how effective the management is. Biotage AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biotage management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biotage management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 438 people.
Please note, the imprecision that can be found in Biotage AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotage AB. Check Biotage AB's Beneish M Score to see the likelihood of Biotage AB's management manipulating its earnings.
Biotage AB Workforce Analysis
Traditionally, organizations such as Biotage AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biotage AB within its industry.Biotage AB Manpower Efficiency
Return on Biotage AB Manpower
| Revenue Per Employee | 2.4M | |
| Revenue Per Executive | 123.2M | |
| Net Income Per Employee | 527.5K | |
| Net Income Per Executive | 26.9M | |
| Working Capital Per Employee | 415.7K | |
| Working Capital Per Executive | 21.2M |
Additional Tools for Biotage Stock Analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.